Aspirin, Iranian Geneva talks, subway rescues and more
An original bottle of Bayer aspirin manufactured and distributed in powder form by Bayer in Germany beginning in 1899. (Bayer/AP)
Some morning news to know:
Aspirin the miracle drug?
It can help prevent heart attacks and strokes. It works a mean cure on headaches. And now, aspirin, that tiny, common pill may reduce the risk of dying in certain cancers. Experts do not think the study warrants healthy people launching into aspirin regimens, but the Guardian's Sarah Boseley thinks that the news has been greeted with a lackluster response.
Iran nuclear talks
After two days of discussions between Iran and members of the U.N. Security Council, the only thing in agreement is that more talks will take place. Iranian President Mahmoud Ahmadinejad wants U.N. sanctions lifted. The United Nations wants to discuss the Iranian nuclear program. No conclusion was made, but to reconvene next month. This is the first time Iran has met with the United Nations in 14 months.
Nobel Prize
Under pressure from China, 19 governments have declared their ambassadors will not be attending the Nobel Peace Prize ceremonies, which will award the prize to Chinese dissident Liu Xiaobo. The countries that have declined the invitations are China, Russia, Kazakhstan, Colombia, Tunisia, Saudi Arabia, Pakistan, Serbia, Iraq, Iran, Vietnam, Afghanistan, Venezuela, the Philippines, Egypt, Sudan, Ukraine, Cuba and Morocco, the New York Times reports.
Hold your breath
In daring subway rescues, a Madrid man barely escapes death when an off-duty police officer pulls him from the tracks.
By
Melissa Bell
| December 7, 2010; 8:05 AM ET
Categories:
The Daily Catch
Save & Share:
Previous: ♪♫ December 7, 1941: A day that will live in infamy
Next: Julian Assange arrested: Is he a 'scientific journalist' or 'megalomaniac'?
No comments have been posted to this entry.
















We encourage users to analyze, comment on and even challenge washingtonpost.com's articles, blogs, reviews and multimedia features.
User reviews and comments that include profanity or personal attacks or other inappropriate comments or material will be removed from the site. Additionally, entries that are unsigned or contain "signatures" by someone other than the actual author will be removed. Finally, we will take steps to block users who violate any of our posting standards, terms of use or privacy policies or any other policies governing this site. Please review the full rules governing commentaries and discussions.